In contrast to recent guidelines, the majority of the intervention trials conducted on the topic till date found a promising role of ICD only in the prevention of SCD in NYHA class II HF. One of the trials which found a significant role of ICD in type III heart failure was underpowered. ...
浙江大学硕士学位论文心脏再同步化治疗NYHAI/II级心力衰竭患者的疗效Meta分析姓名:***请学位级别:硕士专业:心血管学指导教师:**香20120517浙江大学硕士学位论文中文摘要心脏再同步化治疗NYHAI/II级心力衰竭患者的疗效Meta分析中文摘要目的通过Meta分析来评价心脏再同步化治疗对NⅥ{AI/II级、左室射血分数下降、宽QRs...
MyrvangHeleneEBSCO_AspNature Reviews CardiologyMyrvang, H., 2011. Device therapy: Adding CRT to ICD improves outcomes in patients with NYHA class II and III heart failure. Nature Reviews. Cardiology, 8(1), p.4.
doi:10.1056/NEJMoa1009540MyrvangHeleneNature Reviews CardiologyMyrvang, H., 2011. Device therapy: Adding CRT to ICD improves outcomes in patients with NYHA class II and III heart failure. Nature Reviews. Cardiology, 8(1), p.4.
Device therapy: Adding CRT to ICD improves outcomes in patients with NYHA class II and III heart failureNature Reviews Cardiology 8, 4 (2011). doi:10.1038/nrcardio.2010.194Author: Helene M ...doi:10.1038/nrcardio.2010.194MyrvangHeleneNature Reviews Cardiology...
Christman.Heart Failure Decompensation and All-Cause Mortality in Relation to Percent Biventricular Pacing in Patients With Heart Failure[J]. Journal of the American College of Cardiology .2009(4)Heart Failure Decompensation and All-Cause Mortality in Relation to Percent Biventricular Pacing in ...